- Home
- / Entia Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Entia Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$235.6 K
2024-10-29
Revenue
$265.5 K
FY, 2016
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 403.3K | 369.3K | 314.7K | 656.3K | 346.9K | 265.5K |
| Revenue growth, % | 108.5% | -47.1% | -23.5% | |||
| Cost of goods sold | 132.7K | 107.5K | 131.1K | 245.5K | 131.0K | 91.5K |
| Gross profit | 270.6K | 261.8K | 183.6K | 410.9K | 215.9K | 174.0K |
| Gross profit margin, % | 67.1% | 70.9% | 58.3% | 62.6% | 62.2% | 65.5% |
| General and administrative expense | 702.5K | 865.1K | 1.6M | 1.5M | 1.4M | 960.0K |
| Operating expense total | 1.7M | 1.3M | 3.2M | 2.2M | 2.2M | 1.5M |
| EBIT | (1.5M) | (1.1M) | (3.0M) | (1.8M) | (2.0M) | (1.3M) |
| EBIT margin, % | -365.3% | -292.7% | -943.6% | -273.9% | -584.0% | -493.6% |
| Interest income | 192.0 | 4.2K | 9.9K | |||
| Interest expense | 338.9K | 262.9K | 144.7K | |||
| Pre tax profit | (1.7M) | |||||
| Net Income | (1.7M) | (1.3M) | (3.1M) | (2.3M) | (2.3M) | (1.4M) |